News:

Here we provide you with news articles, blogs and tweets on the key aspects of our bioinformatics and drug resistance work.

In this new section of the bioafrica.net website, we disseminate printed and online media coverage of our work and its application in everyday life.


News Latest News

New Scientist


New evidence in Libyan HIV trial

New Scientist - 2006-12-20

New and compelling scientific evidence has emerged in support of five Bulgarian nurses and a Palestinian doctor accused of deliberately spreading HIV to 426 Libyan children in 1998.

The evidence redoubles the international pressure on Libyan president Colonel Muammar al- Gaddafi to ensure that the six are acquitted when the Libyan court issues its verdict on 19 December.

By examining viral extracts from some of the children, Oliver Pybus of the University of Oxford and his colleagues were able to work backwards to establish that specific mutations in 40 per cent of the HIV cases evolved before the nurses arrived at the Al-Fateh Hospital in Benghazi in March 1998. Likewise, 70 per cent of the children with hepatitis C, which can also be spread through dirty needles, contracted it before the arrival of the nurses (de Oliveira T et al. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak - Nature, DOI: 10.1038/nature44836a). The analysis concludes that both viruses spread through poor hospital hygiene.

The big question now is whether the court accepts the evidence even though the trial ended on 4 November. "We'd like it to be heard or taken into account somehow," says Pybus.

More information: Original paper: de Oliveira T et al. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak

Links:

http://evolve.zoo.ox.ac.uk/Evolve/15_mins_files/NewSci.pdf

Publication cited

Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. de Oliveira T, Pybus OG, Rambaut A, Salemi M, Cassol S, Ciccozzi M, Rezza G, Gattinara GC, D'Arrigo R, Amicosante M, Perrin L, Colizzi V, Perno CF; Benghazi Study Group, Nature (2006), 444(7121):836-7.

15 minutes, All news...

Why KRISP? KRISP challenges the status quo to create a scientific environment in South Africa that drives innovations & reverses the brain drain.
From Why KRISP?, date: 2017-12-31

Even with easy access to ARVs, only one in three HIV-positive people will seek them
From KRISP News, date: 2017-12-05

South Africans with HIV miss out on the benefits of early treatment due to a fear of stigma
From KRISP News, date: 2017-12-02
15 minutes, All news...


Page design updated by Tulio de Oliveira, 2015